Results 251 to 260 of about 332,122 (357)

Brief report: Ketamine‐assisted “bridge therapy” for opioid tapering in complex cases

open access: yesThe American Journal on Addictions, EarlyView.
Abstract Background Opioid use disorder (OUD) presents major challenges, especially when combined with chronic pain and psychiatric comorbidities. A 25‐year‐old woman with OUD, chronic pain, and major depressive disorder underwent an 8‐week protocol of intravenous ketamine infusions (0.5 mg/kg weekly) as an adjunct to opioid tapering. Results Methadone
Mariana C. de Oliveira   +11 more
wiley   +1 more source

MAT2A promotes atherosclerotic plaque vulnerability by mediating epigenetic reprogramming of macrophages. [PDF]

open access: yesNat Commun
Du Z   +18 more
europepmc   +1 more source

Economic evidence for licensed ready‐to‐administer intravenous products compared with standard vials and ampoules: a systematic review

open access: yesAnaesthesia, EarlyView.
Summary Introduction Injectable medicines represent a significant proportion of the annual medicines expenditure of the NHS in England, totalling £7 billion ($9.4 billion, €8.0 billion) in 2023. This represents approximately 70% of hospital medicines spending and includes essential treatments delivered at the point of care, such as chemotherapy ...
Suzanne Al‐Rawi   +2 more
wiley   +1 more source

Applied physiology at the bedside: using invasive blood pressure as a true monitoring tool. [PDF]

open access: yesAnn Intensive Care
Bertrand M   +4 more
europepmc   +1 more source

Norepinephrine: Not too Much, too Long

open access: yesShock, 2015
Claude D Martin   +9 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy